Poor Responders Infertile Patients -A Great Clinical Challenge
NCT03402620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2018-06-06
Summary
infertile , poor responders patients who underwent ICSI. The participants were divided into 2 groups according to the starting dose of Gn stimulation. Group I started with 4 ampoules while group II started with 6 ampoules
Conditions
- Invitro Fertilization
Interventions
- DRUG
-
Gonadotropins
Human menopausal gonadotropin 75 IU ampoules start at cycle day 2
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Ahmed Maged, MD · Professor
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-11
- Primary Completion
- 2018-06-04
- Completion
- 2018-06-04
Countries
- Egypt
Study Locations
More Related Trials
-
Long Protocol and Growth Hormone in Poor Responders
NCT02338206 ·Status: COMPLETED ·Phase: PHASE2
-
Protocols of IVF/ICSI in Poor Responders
NCT04356105 ·Status: COMPLETED ·Phase: PHASE3
-
Dual Trigger Versus Booster Dose of HCG
NCT02397642 ·Status: COMPLETED ·Phase: NA
-
Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase
NCT02333253 ·Status: COMPLETED ·Phase: PHASE3
-
Antagonist Protocol in IVF
NCT02335736 ·Status: UNKNOWN ·Phase: PHASE2
-
Three Small Doses of HCG Versus Booster Dose of HCG on Ovum Pickup Day
NCT02397551 ·Status: COMPLETED ·Phase: PHASE4
-
The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles
NCT03209687 ·Status: COMPLETED ·Phase: PHASE4
-
Microflare Protocol in Poor Responders
NCT02185326 ·Status: COMPLETED ·Phase: PHASE4
-
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
NCT02312089 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)
NCT05281341 ·Status: COMPLETED ·Phase: PHASE4
-
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
NCT03996434 ·Status: COMPLETED ·Phase: PHASE4
-
Miniflare Versus Long Protocol in Poor Responders
NCT02681536 ·Status: UNKNOWN ·Phase: NA
-
Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration
NCT02330770 ·Status: RECRUITING ·Phase: PHASE4
-
Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
NCT02736032 ·Status: COMPLETED ·Phase: PHASE3
-
GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT
NCT03039049 ·Status: COMPLETED ·Phase: PHASE3
-
Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response
NCT02736591 ·Status: UNKNOWN ·Phase: PHASE3
-
Delayed Embryo Transfer in Poor Responders
NCT02431689 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response
NCT03373149 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Fasting on ICSI Outcomes in Poor Responders
NCT03714009 ·Status: COMPLETED ·Phase: NA
-
Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI
NCT02741154 ·Status: COMPLETED ·Phase: PHASE4
-
Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI
NCT05951400 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes
NCT05972902 ·Status: UNKNOWN ·Phase: PHASE3
-
Omitting GnRH-antagonist Dose on the Day of Ovulation Trigger
NCT03044756 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intrauterine Injection of Human Chorionic Gonadotropin Before Embryo Transfer in Women With Previous IVF Failure
NCT02329197 ·Status: UNKNOWN ·Phase: PHASE4
-
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
NCT02312076 ·Status: RECRUITING ·Phase: PHASE4